KATHLEEN YANCEY: Open Payments
NPI 1053087114 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 56 payments from 14 companies in 2025. Trend: 2023 $1,486 · 2024 $1,498 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $187 |
| GENZYME CORPORATION | 5 | $180 |
| LEO Pharma Inc. | 9 | $144 |
| PFIZER INC. | 7 | $120 |
| Organon LLC | 9 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $34 |
| Galderma Laboratories, L.P. | 2 | $32 |
Products named: DUPIXENT, ADBRY, SKYRIZI, CIBINQO, RINVOQ, VTAMA, Zoryve, TALTZ.
Industry payments across FL — which companies pay providers there.
